Details for New Drug Application (NDA): 088868
✉ Email this page to a colleague
NDA 088868 describes PHERAZINE VC, which is a drug marketed by Halsey and is included in two NDAs. Additional details are available on the PHERAZINE VC profile page.
The generic ingredient in PHERAZINE VC is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
The generic ingredient in PHERAZINE VC is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for 088868
| Tradename: | PHERAZINE VC |
| Applicant: | Halsey |
| Ingredient: | phenylephrine hydrochloride; promethazine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 5MG/5ML;6.25MG/5ML | ||||
| Approval Date: | Mar 2, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
